UNCY Past Earnings image   This UNCY past earnings page last updated 4/4/2023
UNCY Past Earnings
PeriodPast Earnings DateGAAP
Q4 20223/31/2023-0.510
Q3 202211/14/2022-0.370
Q2 20228/15/2022-0.240
Q1 20225/12/2022-0.240
Q4 20213/31/2022-0.170
Q3 202111/11/2021-0.340
Q2 20218/16/2021-0.130
UNCY Past Revenue
PeriodPast Earnings DateGAAP
Q4 20223/31/2023NA
Q3 202211/14/2022NA
Q2 20228/15/2022NA
Q1 20225/12/2022NA
Q4 20213/31/2022NA
Q3 202111/11/2021NA
Q2 20218/16/2021NA
Quotes delayed 20 minutes

Email EnvelopeFree UNCY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Unicycive Therapeutics (UNCY) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

USPH Past Earnings
UTHR Past Earnings
UTMD Past Earnings
UTRS Past Earnings
VAPO Past Earnings
VAXX Past Earnings
VBIV Past Earnings
VCEL Past Earnings
VCNX Past Earnings
VCYT Past Earnings

UNCY Past Earnings Q&A

What was the best and worst UNCY past earnings results?
For Unicycive Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest UNCY past earnings result in our data set was -0.130/share posted in Q2 2021, while the lowest was in Q4 2022 when UNCY posted -0.510/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2022 when UNCY reported NA in revenue, while the quarter with the lowest revenue in our data set was Q4 2022 at NA of revenue.

  Suggested answer: There are 7 UNCY past earnings results in our data set.

On this page we presented the UNCY past earnings date information for Unicycive Therapeutics. Reviewing that UNCY Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2021, when UNCY posted gaap of -0.130/share. Meanwhile the lowest UNCY past earnings result was in Q4 2022, when UNCY posted gaap of -0.510/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2022 when UNCY reported NA in revenue, while the smallest revenue quarter was Q4 2022 when UNCY reported NA in revenue.

Any self directed investor doing their due diligence on UNCY or any other given stock can benefit from researching all of the Unicycive Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Unicycive Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for UNCY. Thanks for visiting, and the next time you need to research UNCY past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: ETFs Holding BCR, IVR YTD Return, Institutional Holders of BCSA.

 

UNCY Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.